Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1A | P35348 | 4/20 | 0.55 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.55 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.55 |
| ▸ | DRD2 | P14416 | 2/20 | 0.51 |
| ▸ | BRAF | P15056 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8745798 | 0.94 | BRAF (0.56) | ADRA1AADRA1DADRA1BDRD2BRAF | |
| SCHEMBL9144743 | 0.93 | DRD2 (0.51) | ADRA1ADRD2BRAFHTR2AKCNH2 | |
| SCHEMBL8745782 | 0.90 | DRD2 (0.54) | ADRA1AADRA1DADRA1BDRD2BRAF | |
| SCHEMBL8745813 | 0.89 | BRAF (0.49) | ADRA1AADRA1DADRA1BDRD2BRAF | |
| SCHEMBL8745760 | 0.89 | ADRA1A (0.55) | ADRA1AADRA1DADRA1BDRD2BRAF | |
| SCHEMBL8745769 | 0.87 | BRAF (0.55) | ADRA1AADRA1DADRA1BDRD2BRAF | |
| SCHEMBL8745809 | 0.84 | HTR2A (0.60) | ADRA1ADRD2BRAFHTR2AKCNH2 | |
| SCHEMBL8745781 | 0.84 | ADRA1A (0.51) | ADRA1AADRA1DADRA1BDRD2HTR2A | |
| SCHEMBL8745759 | 0.84 | DRD2 (0.59) | DRD2BRAFHTR2AKCNH2DRD3 | |
| Ensaculin SCHEMBL29722503 | 0.83 | HTR2A (0.63) | ADRA1ADRD2HTR2AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0663911-B1 | BENZOPYRANONES, METHOD OF PREPARING THEM AND THEIR USE | SCHWABE WILLMAR GMBH & CO (DE) | 1997-02-05 | — | — | EP | disclosed |
| US-5550129-A | THERAPY FOR NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDERS | WILLMAR SCHWABE GMBH & CO. (DE) | 1996-08-27 | — | — | US | disclosed |